Roivant Sciences Ltd.
ROIVNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $24.54B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $16.41$42.50
- Volume (live)
- -
- Avg. volume (3M)
- 7.73M
Roivant Sciences (ROIV) Stock Price & Financial Analysis
Roivant Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $33.70 - $34.36 |
|---|---|
| 52-Week High | $42.50 |
| 52-Week Low | $16.41 |
| Open | $33.82 |
| Volume (last close) | 4.57M |
| Average Volume (3M) | 7.73M |
| Revenue (TTM) | 7.53M |
|---|---|
| Net Income (TTM) | -266.25M |
| Free Cash Flow (TTM) | -821.06M |
| EPS (TTM) | −$0.37 |
| Profit Margin | -3534.88% |
| Operating Margin | -18140.92% |
| Return on Equity (ROE) | -5.41% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 24.54B |
|---|---|
| Shares Outstanding | 720.78M |
| Price to Sales (P/S) | 3257.47 |
| Price to Book (P/B) | 4.98 |
| EV/EBITDA | -54.59 |
| 50-Day MA | $36.68 |
|---|---|
| 200-Day MA | $30.67 |
| 1-Year Change | +98.95% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Roivant Sciences at a Glance
As of the Oct 15, 2026 close, Roivant Sciences (ROIV) has a market capitalization of $24.54B. The stock trades at 3257.5× sales. Over the trailing twelve months it lost $266.25M on revenue of $7.53M and burned $821.06M of free cash flow. Revenue fell 67.6% year over year.
As of its latest reported balance sheet, it holds $1.25B in cash and securities against $107.15M of debt, a net cash position of $1.14B.
Roivant Sciences does not currently pay a dividend.
The share price is up 98.9% over the past year. At $34.04 (the Oct 15, 2026 close) it sits within its 52-week range of $16.41 to $42.50, above its 200-day moving average of $30.67.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $46.64, 37.0% above the Oct 15, 2026 close.
Frequently Asked Questions About Roivant Sciences
What is the current stock price for ROIV?
As of the Oct 15, 2026 close, ROIV stock trades at $34.04. The 52-week range is $16.41–$42.50, with a day range of $33.70–$34.36.
What is the P/E ratio for ROIV?
The P/E ratio (Price-to-Earnings) for ROIV is shown in the Key Statistics section. This valuation metric helps compare Roivant Sciences Ltd. to industry peers.
Does ROIV pay dividends?
Roivant Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ROIV?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for ROIV is Buy. The average 12-month price target is $46.64, a 37.0% upside from the Oct 15, 2026 close of $34.04.
What is the market cap of ROIV?
As of the Oct 15, 2026 close, Roivant Sciences's market capitalization is $24.54B, classifying it as a large-cap company. Roivant Sciences operates in the Healthcare sector within the Biotechnology industry.